Topics

FDA issues warning letter to Health Pharma for cGMP violations

07:36 EST 16 Jan 2020 | European Pharmaceutical Review

An inspection at a manufacturing facility belonging to Health Pharma has revealed breaches of cGMP regulations, causing the FDA to send a warning letter.

The post FDA issues warning letter to Health Pharma for cGMP violations appeared first on European Pharmaceutical Review.

Original Article: FDA issues warning letter to Health Pharma for cGMP violations

NEXT ARTICLE

More From BioPortfolio on "FDA issues warning letter to Health Pharma for cGMP violations"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...